New patent for Ardelyx Inc drug IBSRELA

   October 29, 2022    Comments Off on New patent for Ardelyx Inc drug IBSRELA    Posted in: Patent Added

Annual Drug Patent Expirations for IBSRELA Ibsrela is a drug marketed by Ardelyx Inc and is included in one NDA. There are four patents protecting this drug. This drug has…

The post New patent for Ardelyx Inc drug IBSRELA appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog